Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_assertion type Assertion NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_head.
- NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_assertion description "[Therefore, the aim of the present study was to examine in the human neuroblastoma SH-SY5Y cell line the impact of a typical (haloperidol) and an atypical (quetiapine) antipsychotic on the expression of genes encoding the key enzymes of the antioxidant metabolism (Cu, Zn superoxide dismutase; Mn superoxide dismutase; glutathione peroxidase; catalase) and enzymes of the glutathione metabolism (gamma-glutamyl cysteine synthetase, glutathione-S-transferase, gamma-glutamyltranspeptidase, glutathione reductase).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_provenance.
- NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_assertion evidence source_evidence_literature NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_provenance.
- NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_assertion SIO_000772 19101687 NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_provenance.
- NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_assertion wasDerivedFrom befree-2016 NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_provenance.
- NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_assertion wasGeneratedBy ECO_0000203 NP710675.RAAUb0aVYg7s5n2Evp-S_j9y2IuQ8TD4x1Ad0nQcL3KBc130_provenance.